Aimei Health Technology Co., Ltd (NASDAQ:AFJK – Get Free Report) was the target of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 1,000 shares, a decrease of 56.5% from the October 31st total of 2,300 shares. Based on an average daily trading volume, of 34,200 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are sold short.
Aimei Health Technology Price Performance
AFJK stock opened at $10.60 on Friday. Aimei Health Technology has a one year low of $10.15 and a one year high of $10.69. The firm has a 50-day simple moving average of $10.54 and a two-hundred day simple moving average of $10.44.
Hedge Funds Weigh In On Aimei Health Technology
Several hedge funds and other institutional investors have recently bought and sold shares of the business. Virtu Financial LLC acquired a new position in Aimei Health Technology in the 3rd quarter worth approximately $123,000. Glazer Capital LLC lifted its position in shares of Aimei Health Technology by 3.4% during the 3rd quarter. Glazer Capital LLC now owns 608,670 shares of the company’s stock valued at $6,379,000 after buying an additional 19,896 shares in the last quarter. Mizuho Securities USA LLC lifted its holdings in Aimei Health Technology by 60.7% in the 3rd quarter. Mizuho Securities USA LLC now owns 442,778 shares of the company’s stock valued at $4,627,000 after purchasing an additional 167,223 shares in the last quarter. Wolverine Asset Management LLC lifted its holdings in Aimei Health Technology by 8.6% in the 3rd quarter. Wolverine Asset Management LLC now owns 539,039 shares of the company’s stock valued at $5,649,000 after purchasing an additional 42,843 shares in the last quarter. Finally, Shaolin Capital Management LLC lifted its holdings in Aimei Health Technology by 33.3% in the 2nd quarter. Shaolin Capital Management LLC now owns 400,000 shares of the company’s stock valued at $4,140,000 after purchasing an additional 100,000 shares in the last quarter. Institutional investors and hedge funds own 45.58% of the company’s stock.
Aimei Health Technology Company Profile
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Further Reading
- Five stocks we like better than Aimei Health Technology
- What is the Euro STOXX 50 Index?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Why Invest in 5G? How to Invest in 5G Stocks
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Aimei Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimei Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.